Varian's (VAR) Halcyon To Treat Patients At Japan's Hospital

Zacks Investment Research | Apr 30, 2019 10:00PM ET

Varian Medical Systems, Inc. (NYSE:VAR) recently announced that Ofuna Chuo Hospital, Kamakura City, Kanagawa Prefecture is the first clinic in Japan to begin cancer treatment with the Halcyon radiotherapy system.

This secures Varian’s hold in the global radiation therapy space.

Halcyon in Focus

The Halcyon system has been designed to provide technologically-advanced, high-quality treatment to cancer patients. The platform provides simplified and enhanced image-guided volumetric intensity-modulated radiotherapy. The product claims to be much superior to traditional technologies, thanks to the speed of treatment and improved quality of patient care it offers.

The flagship platform has seen a slew of developments in recent times.

Notably, Kenya’s The Nairobi West Hospital is the first clinic in the country and in West, Central, and East Africa to begin treating cancer patients using the Halcyonradiotherapy system.

Moreover, a 62-year-old male, suffering from thyroid cancer, became the first patient in Malaysia to receive Halcyon treatment at Beacon hospital, Selangor, Malaysia. (Read More: Zacks Investment Research

Get The News You Want

Read market moving news with a personalized feed of stocks you care about.

Get The App

Written By: Zacks Investment Research

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Show moreShow Less